HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and ...

The more cautious voices point to Hims’s high P/E ratio and recent volatility, warning that the stock could cool off after its sharp run-up. That said, a few analysts are still pretty optimistic. They ...

HIMS accelerates global growth with ZAVA buyout, Canadian launch, and soaring EPS estimates pointing to 177.8% upside.

If you suffered losses exceeding $50,000 in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your ...

On today's episode of The Roommates Show the guys hand out their NBA Awards! They relive their most controversial moments, ...

Justin Penik invites the Giants RB1 Tyrone Tracy Jr. to the Jomboy Media Office to talk about his rookie season, goals going ...

Kodiak Robotics, Inc. ("Kodiak"), a leading provider of AI-powered autonomous vehicle technology, today announced it has ...

Shark attack survivor Paul de Gelder joins us to talk Navy diving, bull sharks, and his wild return in Air Jaws and more ...

Analysts have provided Laboratory Corp with 8 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $276.5, suggesting a potential 9.69% upside.

Dr. Garshick suggests pairing tretinoin with hyaluronic acid and ceramides to combat any dryness or irritation that you might ...

Delhi CM to inaugurate 34 Ayushman Arogya Mandirs & 8 Jan Aushadhi Kendras, enhancing healthcare accessibility in the city.

Morningstar analyst Nicolas Owens breaks down airline earnings, as Delta restores its guidance and signals a clearer outlook ...